Need further assistance? Please call Member Services at 1-800-333-0663
Should You Have a Breast Cancer Genetic Test?
Tests for mutations that can raise your risk aren t for everyone By Catherine Roberts
Share this article
Share this article
BETHESDA, Md., Jan. 27, 2021 /PRNewswire/ The ACMG Annual Clinical Genetics Meeting will be a fully virtual meeting in 2021 and continues to provide groundbreaking research and the latest advances in medical genetics, genomics and personalized medicine. To be held April 13–16, experience four days of professional growth, education, networking and collaboration with colleagues from around the world and discover what s shaping the future of genetics and genomics, including several sessions on COVID-19. The 2021 ACMG Meeting Virtual Experience is designed to offer a variety of engaging and interactive educational formats and types of sessions from Scientific Sessions and Workshops to TED-Style Talks, Case-based Sessions, Platform Presentations and Short Courses. The 2021 ACMG Meeting Virtual Experience has something for everyone on the genetics healthcare team and will be available to participate in from the convenience of your home or office
Dr. Neil Hanchard joins NHGRI as a clinical investigator
SHARE:
Dr. Hanchard will lead the new Childhood Complex Disease Genomics Section.
The National Human Genome Research Institute (NHGRI) has appointed Neil Hanchard, M.D., Ph.D., as a clinical investigator within the Medical Genomics and Metabolic Genetics Branch (MGMGB) in the NHGRI Division of Intramural Research. Dr. Hanchard will head the Childhood Complex Disease Genomics Section within the MGMGB.
“We are delighted to welcome Neil Hanchard to the NHGRI Intramural Research Program,” said Dan Kastner, M.D., Ph.D., NHGRI s scientific director. “Neil and his team will bring new energy and academic vigor to studies of the genomics of African ancestral populations, health disparities in underrepresented populations and precision medicine. Neil is an intellectual giant who will bring his outstanding scientific track record to the institute.”
Press release content from Business Wire. The AP news staff was not involved in its creation.
Avellino Exceeds 1 Million COVID-19 Tests in 2020 and Welcomes New Executive Team Hires In 2021
January 14, 2021 GMT
MENLO PARK, Calif. (BUSINESS WIRE) Jan 14, 2021
Avellino Lab announced today that the company performed over 1 million AvellinoCoV2 COVID-19 tests since March 2020, and has further expanded the company’s executive team to drive additional development and commercial growth in 2021. Chief Scientific Officer, Nazneen Aziz, PhD; and Global Head of Sales and Marketing, Joseph Boyd have joined the growing precision medicine company adding additional scientific and commercial expertise.
Nazneen Aziz, PhD; Chief Scientific Officer
E-Mail
The National Human Genome Research Institute (NHGRI) within the National Institutes of Health (NIH) has released a new action agenda for a diverse genomics workforce. This ambitious set of goals, objectives, and implementation strategies details NHGRI s plans for enhancing the diversity of the genomics workforce by 2030. To reach its full potential, the field of genomics requires a workforce that better reflects the diversity of the U.S. population, NHGRI Director Eric Green, M.D., Ph.D., said. Fostering an appropriately diverse genomics workforce of the future requires an immediate and substantial commitment of attention and resources. Our new action agenda aims to bring both short- and long-term changes that will make genomics a more-inclusive discipline.